Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

Escient Pharmaceuticals Announces IND Clearance by FDA to Start Phase 1 Study of EP262, a First-in-Class Oral MRGPRX2 Antagonist for Mast Cell Mediated Disorders
Read Me

Cidara Therapeutics and WuXi XDC Expand Collaboration for IND-enabling CMC Development to Advance Cidara’s CD73 Oncology DFC Program
Read Me

Rallybio Announces Appointment of Jonathan I. Lieber as Chief Financial Officer
Read Me

scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update
Read Me

Artiva Biotherapeutics Receives FDA Fast Track Designation for AB-101

Pushing the healthcare industry forward

$ 0 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $450M from 5AM Ventures VII and $300M from 5AM Opportunities II.
0

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
0

ONGOING CLINICAL TRIALS

Historically our portfolio companies have had over 80,000 patients enrolled across 8,000 test sites in clinical trials.

San Francisco, CA

Boston, MA

© 2023 5AM Venture Management LLC